oncology– tag –
-
Why Does the Heart Rarely Get Cancer? — Mechanical Load Suppresses Tumour Growth via Nesprin-2 | Science April 2026
Science April 23, 2026 (Ciucci et al.) finally answered why the heart almost never develops cancer. Three experimental systems — genetic mouse model + heterotopic heart transplantation unloading + engineered heart tissues — established that mechanical load directly suppresses cancer cell proliferation. Mechanism: Nesprin-2 → histone methylation (H3K9me3) → chromatin compaction → reduced proliferation. Opens a new therapeutic axis: mechanical-stimulation therapy. -
Oncology Drug Approval News Flash FDA approves nivolumab (Opdivo) with AVD chemotherapy for previously untreated advanced classical Hodgkin lymphoma (and converts prior accelerated approvals in relapsed/refractory cHL to traditional approval)
On March 20, 2026, the U.S. FDA approved nivolumab (Opdivo) in combination with doxorubicin, vinblastine, and dacarbazine (AVD) for adults and pediatric patients aged 12 years and older with previously untreated, Stage III or IV classica... -
Why Solid Tumors Are Hard for CAR-T: Reading the 3 Barriers That Define Today’s Clinical Bottleneck | Frontier of Therapy Series | CAR-T A3 [Beginner]
New here?→ A0: What is CAR-T therapy? The big picture + index→ A1: Where CAR-T is used today (blood cancers first) New here?→ A0: What is CAR-T therapy? The big picture + index→ A1: Where CAR-T is used today (blood cancers first) What yo... -
Current Standing of CAR-T Toxicity Management: 5 Implementation Challenges Across Site Ops, Long-Term Safety, and Regulation | Frontier of Therapy Series | CAR-T B2 [Expert]
Prefer the beginner overview first?→ A0: What is CAR-T therapy? The big picture + index→ A2: CAR-T side effects without panic (what happens, what to m Prefer the beginner overview first?→ A0: What is CAR-T therapy? The big picture + inde... -
How to Read CAR-T Side Effects: A 3-Axis Map of CRS, ICANS, and Cytopenia for Patients Without Panic | Frontier of Therapy Series | CAR-T A2 [Beginner]
New here? Start with the basics and where CAR-T is used today.→ A0: What Is CAR-T Therapy? The Big Picture + Series Index→ A1: Where CAR-T Is Used Tod New here? Start with the basics and where CAR-T is used today.→ A0: What Is CAR-T Ther... -
FDA-Approved CAR-T Landscape: 7 Products and the Label Logic Behind Their Indications
Eleven CAR-T products have earned FDA approval, each targeting a specific cell, antigen, and disease. A single well-made table is worth a month of white papers—here is how to read it, and where the next approvals will land. Prefer the be... -
Where CAR-T Is Used Today: Reading the Indication Map Through 5 Blood Cancers and Today’s Standing | Frontier of Therapy Series | CAR-T A1 [Beginner]
New here? If you haven’t read the introduction, it will make this post much easier to follow.→ A0: What Is CAR-T Therapy? The Big Picture + Series Ind New here? If you haven’t read the introduction, it will make this post much easier to ... -
CAR-T at a Glance: A Beginner’s Map of Cells, Targets, and Why It Works
How to use this series (two-layer linkage: Beginner → Expert) This series explains CAR-T therapy in a stepwise way so that readers who are new to the term can first grasp the big picture (Layer A), and then move This series explains CAR-... -
Oncology Drug Approval News Flash FDA approves teclistamab (Tecvayli) plus daratumumab hyaluronidase-fihj for relapsed/refractory multiple myeloma (and converts Tecvayli monotherapy from accelerated to traditional approval)
On March 5, 2026, the U.S. FDA approved teclistamab (Tecvayli), a BCMA×CD3 bispecific antibody, in combination with daratumumab hyaluronidase-fihj for adults with relapsed or refractory multiple myeloma (RRMM) who have received at least ... -
Cancer Worries Episode 9 — Childhood Cancer: 4 Care Dimensions That Distinguish Pediatric from Adult Oncology
“My child seems unusually tired.” “The fever keeps coming back.” “Bruises appear more easily.” Childhood cancers are uncommon, but once the thought ap “My child seems unusually tired.” “The fever keeps coming back.” “Bruises appear more ... -
Cancer Worries Episode 8 — Brain Tumors: 4 Treatment Crossroads When the Tumor Is Inside the Skull
“My headaches are getting worse.” “I had my first seizure.” “I feel my speech is off.” Brain tumors are emotionally charged, and the fear can escalate “My headaches are getting worse.” “I had my first seizure.” “I feel my speech is off.”... -
Cancer Worries Episode 7 — Ovarian Cancer: 4 Points to Organize When Facing a Late-Detection Diagnosis
“I’m constantly bloated.” “I feel full quickly.” “I’m going to the bathroom more often.” Ovarian cancer is a topic where uncertainty can quickly fuel “I’m constantly bloated.” “I feel full quickly.” “I’m going to the bathroom more often.... -
Cancer Worries Episode 6 — Pancreatic Cancer: Reading the Treatment Map When Survival Numbers Feel Heavy
“Pancreatic cancer is hard to detect.” “Symptoms are vague.” That uncertainty often fuels anxiety and a deep search spiral. “Pancreatic cancer is hard to detect.” “Symptoms are vague.” That uncertainty often fuels anxiety and a deep sear... -
Zongertinib FDA承認 (Boehringer Ingelheim): What the HER2 TKD Approval Means for NSCLC Sequencing
FDA approval summary On February 26, 2026, the U.S. Food and Drug Administration (FDA) granted accelerated approval to the kinase inhibitor zongertinib (Hernexeos, Boehringer Ingelheim) for an expanded indication in adult patients with u... -
BRAF V600E CRC: What FDA’s Endorsement of Encorafenib + Cetuximab + Chemo Reshapes in 1L
FDA approval summary On February 24, 2026, the U.S. Food and Drug Administration (FDA) granted traditional approval to encorafenib (Braftovi, Array BioPharma Inc., a subsidiary of Pfizer Inc.) in combination with cetuximab and fluorourac... -
Cancer Worries Episode 5 — Prostate Cancer: 5 Decision Points from Active Surveillance to Advanced Treatment
“My PSA is high.” “My PSA keeps creeping up.” “They told me to repeat the test.” Prostate cancer often starts with a number, which can easily amplify “My PSA is high.” “My PSA keeps creeping up.” “They told me to repeat the test.” Prosta... -
Cancer Worries Episode 3 — Metastasis: 4 Frames for Understanding How Cancer Spreads and What That Changes
“My stomach feels uncomfortable.” “I’ve had indigestion for weeks.” “My screening result says I need follow-up.” “I tested positive for H. pylori.” St “My stomach feels uncomfortable.” “I’ve had indigestion for weeks.” “My screening resu... -
Cancer Worries Episode 4 — Breast Cancer: 4 Subtype Pathways That Shape Today’s Personalized Treatment
“Is this a lump?” “Why does this side look different?” “There’s nipple discharge.” Breast cancer searches can quickly become overwhelming. “Is this a lump?” “Why does this side look different?” “There’s nipple discharge.” Breast cancer s... -
Cancer Worries Episode 2 — Colorectal Cancer: 5 Checkpoints That Reshape the Path from Screening to Treatment
“I noticed blood in my stool.” “My bowel habits have changed.” “My screening stool test came back positive.” Once you start searching, the amount of i “I noticed blood in my stool.” “My bowel habits have changed.” “My screening stool tes... -
Cancer Worries Episode 1 — Lung Cancer: 4 Decision Axes That Open the Modern Treatment Landscape
“My cough won’t go away.” “I get short of breath.” “My health check X-ray showed a shadow.” Once you start searching, it’s easy to get overwhelmed and “My cough won’t go away.” “I get short of breath.” “My health check X-ray showed a sha...
